Provided by Tiger Trade Technology Pte. Ltd.

Arrowhead Pharmaceuticals

82.39
-2.5200-2.97%
Post-market: 82.640.2500+0.30%18:18 EDT
Volume:1.60M
Turnover:130.74M
Market Cap:11.61B
PE:-36.08
High:83.76
Open:83.13
Low:80.75
Close:84.91
52wk High:95.49
52wk Low:22.73
Shares:140.86M
Float Shares:122.00M
Volume Ratio:1.57
T/O Rate:1.31%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.2838
EPS(LYR):-0.0122
ROE:-55.21%
ROA:-8.10%
PB:24.93
PE(LYR):-6,757.16

Loading ...

Movement Alert|Arrowhead Pharmaceuticals Rises 8.64% in Pre-Market Trading, Core Pipeline Plozasiran Delivers Strong Results Across Multiple Key Trials

Market Focus
·
Jul 22

Arrowhead Pharma Announces Press Release on Plozasiran Phase 3 Shasta-3 and Shasta-4 Topline Results

Reuters
·
Jul 22

Arrowhead Pharmaceuticals - Plozasiran Shows Significant Reduction in Acute Pancreatitis Events, 100% in High-risk Patients

THOMSON REUTERS
·
Jul 22

Arrowhead Pharmaceuticals - Plozasiran Demonstrates Consistent Safety Profile with no New Safety Signals

THOMSON REUTERS
·
Jul 22

Arrowhead Pharmaceuticals - Plozasiran Achieves 79% and 81% Median Triglyceride Reduction in Shasta-3 and Shasta-4

THOMSON REUTERS
·
Jul 22

Arrowhead Pharmaceuticals - to File Supplemental Nda for Plozasiran with U.S. FDA Before End of 2026

THOMSON REUTERS
·
Jul 22

Press Release: Arrowhead Pharmaceuticals to Webcast Fiscal 2026 Third Quarter Results

Dow Jones
·
Jul 21

Is Arrowhead Pharmaceuticals (ARWR) Undervalued Or Is Its Pipeline Promise Already Priced In?

Simply Wall St.
·
Jul 18

Arrowhead Pharmaceuticals is Maintained at Overweight by JP Morgan

Dow Jones
·
Jul 18

Arrowhead Pharmaceuticals : JP Morgan Raises Target Price to $95 from $88

THOMSON REUTERS
·
Jul 17

U.S. Research Roundup-ibm, MSCI, US Bancorp

Reuters
·
Jul 17

Stifel Initiates Arrowhead Pharmaceuticals at Buy With $98 Price Target

MT Newswires Live
·
Jul 14

Arrowhead Pharmaceuticals : Stifel Initiates Coverage with Buy Rating; Target Price $98

THOMSON REUTERS
·
Jul 14

Analysts Offer Insights on Healthcare Companies: Arrowhead Pharmaceuticals (ARWR) and BrightSpring Health Services, Inc. (BTSG)

TIPRANKS
·
Jul 14

Arrowhead initiated with a Buy at Stifel

TIPRANKS
·
Jul 14

Can Biogen Convince Skeptics That Cutting a Rogue Protein Slows Alzheimer's?

Dow Jones
·
Jul 13

Arrowhead Pharmaceuticals Inc Stock (ARWR) Moved Down by 7.27% on Jul 10: What Signal Does It Send?

TradingKey
·
Jul 11

Movement Alert|Arrowhead Research Corporation Falls 7.92% in Regular Trading, Trading at $77.45

Market Focus
·
Jul 11

Arrowhead Pharmaceuticals (ARWR) Is Up 6.6% After Russell Index Upgrade Has The Bull Case Changed?

Simply Wall St.
·
Jul 09

Analysts Offer Insights on Healthcare Companies: Eton Pharmaceuticals (ETON), Tarsus Pharmaceuticals (TARS) and Arrowhead Pharmaceuticals (ARWR)

TIPRANKS
·
Jul 06